Cargando…

Label-free in vitro assays predict the potency of anti-disialoganglioside chimeric antigen receptor T-cell products

BACKGROUND AIMS: Chimeric antigen receptor (CAR) T cells have demonstrated remarkable efficacy against hematological malignancies; however, they have not experienced the same success against solid tumors such as glioblastoma (GBM). There is a growing need for high-throughput functional screening pla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Logun, Meghan, Colonna, Maxwell B., Mueller, Katherine P., Ventarapragada, Divya, Rodier, Riley, Tondepu, Chaitanya, Piscopo, Nicole J., Das, Amritava, Chvatal, Stacie, Hayes, Heather B., Capitini, Christian M., Brat, Daniel J., Kotanchek, Theresa, Edison, Arthur S., Saha, Krishanu, Karumbaiah, Lohitash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159906/ https://www.ncbi.nlm.nih.gov/pubmed/36849306 http://dx.doi.org/10.1016/j.jcyt.2023.01.008

Ejemplares similares

The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALL
por: Forsberg, Matthew H, et al.
Publicado: (2018)

Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer
por: Reppel, Loïc, et al.
Publicado: (2022)

Chondroitin Sulfate Glycosaminoglycan Scaffolds for Cell and Recombinant Protein‐Based Bone Regeneration
por: Andrews, Seth, et al.
Publicado: (2019)

Bispecific antibody does not induce T-cell death mediated by chimeric antigen receptor against disialoganglioside GD2
por: Hoseini, Sayed Shahabuddin, et al.
Publicado: (2017)

Cross-presentation of Disialoganglioside GD3 to Natural Killer T Cells
por: Wu, Dianna Y., et al.
Publicado: (2003)

Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes
por: Erber, Ramona, et al.
Publicado: (2021)

AutoRG: An automatized reach-to-grasp platform technology for assessing forelimb motor function, neural circuit activation, and cognition in rodents
por: Forghani, Rameen, et al.
Publicado: (2023)

Neurostimulation and Reach-to-Grasp Function Recovery Following Acquired Brain Injury: Insight From Pre-clinical Rodent Models and Human Applications
por: Latchoumane, Charles-Francois V., et al.
Publicado: (2020)

Identification and Tumour-Binding Properties of a Peptide with High Affinity to the Disialoganglioside GD2
por: Müller, Jan, et al.
Publicado: (2016)

Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy
por: Nazha, Bassel, et al.
Publicado: (2020)

Pharmacokinetics of the disialoganglioside, G(D2), a circulating tumor biomarker for neuroblastoma, in nonhuman primates
por: Balis, Frank M., et al.
Publicado: (2021)

Disialoganglioside GD2-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in Tumors of Neuroectodermal Origin
por: Inagaki, Fuyuki F., et al.
Publicado: (2022)

Structure Based Refinement of a Humanized Monoclonal Antibody That Targets Tumor Antigen Disialoganglioside GD2
por: Ahmed, Mahiuddin, et al.
Publicado: (2014)

Predicting T‐cell quality during manufacturing through an artificial intelligence‐based integrative multiomics analytical platform
por: Odeh‐Couvertier, Valerie Y., et al.
Publicado: (2022)

Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins
Publicado: (1986)

Disialoganglioside GD2 distributes preferentially into substrate- associated microprocesses on human melanoma cells during their attachment to fibronectin
Publicado: (1986)

Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies
por: Shankar, Keerthana, et al.
Publicado: (2020)

Extracellular matrix-based intracortical microelectrodes: Toward a microfabricated neural interface based on natural materials
por: Shen, Wen, et al.
Publicado: (2015)

Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells
por: Lin, Jin-Jin, et al.
Publicado: (2014)

Common muscle synergies for balance and walking
por: Chvatal, Stacie A., et al.
Publicado: (2013)

Production and characterization of virus-free, CRISPR-CAR T cells capable of inducing solid tumor regression
por: Mueller, Katherine P, et al.
Publicado: (2022)

Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD(2) Coated Nanoparticles
por: Tivnan, Amanda, et al.
Publicado: (2012)

Tumor Vascular Permeability to a Nanoprobe Correlates to Tumor-Specific Expression Levels of Angiogenic Markers
por: Karathanasis, Efstathios, et al.
Publicado: (2009)

Impact of stereopure chimeric backbone chemistries on the potency and durability of gene silencing by RNA interference
por: Liu, Wei, et al.
Publicado: (2023)

An Arg-Gly-Asp-directed receptor on the surface of human melanoma cells exists in an divalent cation-dependent functional complex with the disialoganglioside GD2
Publicado: (1987)

Chronic Electrical Stimulation Promotes the Excitability and Plasticity of ESC-derived Neurons following Glutamate-induced Inhibition In vitro
por: Latchoumane, Charles-Francois V., et al.
Publicado: (2018)

Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumors
por: Cheng, Ming, et al.
Publicado: (2016)

Vaccinia Virus Shuffling: deVV5, a Novel Chimeric Poxvirus with Improved Oncolytic Potency
por: Ricordel, Marine, et al.
Publicado: (2018)

For High Potencies
por: Fincke, B.
Publicado: (1897)

An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells
por: Lieberman, Nicole A. P., et al.
Publicado: (2018)

Intranasal Corticosteroids: Topical Potency, Systemic Activity and Therapeutic Index
por: Daley-Yates, Peter T, et al.
Publicado: (2021)

Inhibition of Cholesterol Esterification Enzyme Enhances the Potency of Human Chimeric Antigen Receptor T Cells against Pancreatic Carcinoma
por: Zhao, Lei, et al.
Publicado: (2020)

Reforming the Chimeric Antigen Receptor by Peptide Towards Optimized CAR T Cells With Enhanced Anti-Cancer Potency and Safety
por: Liu, Cuijuan, et al.
Publicado: (2022)

Chimeric Antigen Receptors Directed at Mutant KRAS Exhibit an Inverse Relationship Between Functional Potency and Neoantigen Selectivity
por: Tokatlian, Talar, et al.
Publicado: (2022)

Development of a Robust Consensus Modeling Approach for Identifying Cellular and Media Metabolites Predictive of Mesenchymal Stromal Cell Potency
por: Van Grouw, Alexandria, et al.
Publicado: (2023)

Reduced Levels of Membrane-Bound Alkaline Phosphatase Are Common to Lepidopteran Strains Resistant to Cry Toxins from Bacillus thuringiensis
por: Jurat-Fuentes, Juan Luis, et al.
Publicado: (2011)

Antitumor Potency of an Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, Lisocabtagene Maraleucel in Combination With Ibrutinib or Acalabrutinib
por: Qin, Jim S., et al.
Publicado: (2020)

High Potency Allœpathy
por: Gilbert, Charles B.
Publicado: (1890)

Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments
por: Cuzzubbo, Stefania, et al.
Publicado: (2021)

Inhibitors of VPS34 and lipid metabolism suppress SARS-CoV-2 replication
por: Silvas, Jesus A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_osuu93l6stiemlsdggd1k8mc74